156 related articles for article (PubMed ID: 6180542)
21. Testis tumor markers: how accurate are they?
deVere White R; Karian S; Hong WK; Olsson CA
J Urol; 1981 May; 125(5):661-3. PubMed ID: 6164799
[No Abstract] [Full Text] [Related]
22. Cisplatin combination chemotherapy for advanced germ-cell testicular tumours.
Taylor RE; Duncan W; Davey P; Munro AJ; Cornbleet MA
Br J Urol; 1985 Oct; 57(5):567-73. PubMed ID: 2415203
[TBL] [Abstract][Full Text] [Related]
23. Combination chemotherapy with cis-diammine-dichloro-platinum, vinblastine, and bleomycin in advanced testicular non-seminoma.
Stoter G; Sleijfer DT; Vendrik CP; Schraffordt Koops H; Struyvenberg A; Van Oosterom AT; Brouwers TM; Pinedo HM
Lancet; 1979 May; 1(8123):941-5. PubMed ID: 87614
[TBL] [Abstract][Full Text] [Related]
24. Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer.
de Wit R; Sylvester R; Tsitsa C; de Mulder PH; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; van Oosterom AT; Boven E; Vermeylen K; Stoter G
Br J Cancer; 1997; 75(3):432-5. PubMed ID: 9020492
[TBL] [Abstract][Full Text] [Related]
25. Reduced platelet survival following chemotherapy with vinblastine, bleomycin and cis-platinum for testicular teratoma.
Rees GJ; Slade RR; Hopes P
Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1125-9. PubMed ID: 6186497
[TBL] [Abstract][Full Text] [Related]
26. Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).
de Bono JS; Paul J; Simpson A; Anthoney A; Kirk D; Underwood M; Graham J; Kaye SB
Br J Cancer; 2000 Aug; 83(4):426-30. PubMed ID: 10945485
[TBL] [Abstract][Full Text] [Related]
27. Further advances in the management of malignant teratomas of the testis and other sites.
Newlands ES; Begent RH; Rustin GJ; Parker D; Bagshawe KD
Lancet; 1983 Apr; 1(8331):948-51. PubMed ID: 6188011
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors for favorable outcome in disseminated germ cell tumors.
Birch R; Williams S; Cone A; Einhorn L; Roark P; Turner S; Greco FA
J Clin Oncol; 1986 Mar; 4(3):400-7. PubMed ID: 2419524
[TBL] [Abstract][Full Text] [Related]
29. Combination chemotherapy for testicular tumours.
McElwain TJ; Peckham MJ
Proc R Soc Med; 1974 Apr; 67(4):297-300. PubMed ID: 4141774
[No Abstract] [Full Text] [Related]
30. Tumour markers in testicular tumours.
Chisholm GD
Prog Clin Biol Res; 1985; 203():81-91. PubMed ID: 2421346
[No Abstract] [Full Text] [Related]
31. A graphical method to analyze serum tumor marker decay in nonseminomatous testis tumors.
Lo RK; Johnson DE
J Urol; 1984 May; 131(5):896-8. PubMed ID: 6200617
[TBL] [Abstract][Full Text] [Related]
32. Quantification of alpha-fetoprotein and beta-HCG in testis tumor patients.
Dunzendorfer U; Jurincic C
Urol Int; 1987; 42(4):248-53. PubMed ID: 2445089
[TBL] [Abstract][Full Text] [Related]
33. [Choriocarcinoma of the testis - tumor markers in chemotherapy].
Fliege R; Mann K; Hartenstein R; Löhrs U; Lamerz R
Internist (Berl); 1981 Oct; 22(10):645-8. PubMed ID: 6170600
[No Abstract] [Full Text] [Related]
34. Discordant human chorionic gonadotropin results giving rise to inappropriate therapy in a case of testicular cancer.
Bulger KN; Hesketh PJ; Babayan RK
J Urol; 1989 Dec; 142(6):1574-5. PubMed ID: 2479778
[TBL] [Abstract][Full Text] [Related]
35. [Clinical studies of testicular tumor. II. Analysis of 30 patients with nonseminomatous testicular tumor].
Tsukamoto T; Kumamoto Y; Ohmura K; Tsunekawa T; Yamazaki K
Hinyokika Kiyo; 1986 Jul; 32(7):999-1011. PubMed ID: 2430437
[TBL] [Abstract][Full Text] [Related]
36. Combination chemotherapy for metastatic malignant teratoma of testis.
Wilkinson P; Gibb R; Read G
Lancet; 1979 Jun; 1(8127):1185. PubMed ID: 86898
[No Abstract] [Full Text] [Related]
37. Successful treatment of good-risk disseminated testicular cancer with cisplatin, bleomycin, and reduced-dose vinblastine.
Pizzocardo G; Salvioni R; Zanoni F; Milani A; Piva L
Cancer; 1986 Jun; 57(11):2114-8. PubMed ID: 2421865
[TBL] [Abstract][Full Text] [Related]
38. Late relapse after adjuvant chemotherapy for stage II testicular cancer.
Weiss RB; Natale RB; Sesterhenn IA
N Engl J Med; 1990 Aug; 323(5):350. PubMed ID: 1694968
[No Abstract] [Full Text] [Related]
39. Discordance of human chorionic gonadotropin and alpha-fetoprotein in testicular teratocarcinomas.
Braunstein GD; McIntire KR; Waldmann TA
Cancer; 1973 May; 31(5):1065-8. PubMed ID: 4122298
[No Abstract] [Full Text] [Related]
40. Surgery in patients with advanced germ cell malignancy following a clinical partial response to chemotherapy.
Reddel RR; Thompson JF; Raghavan D; Tattersall MH; Levi JA; Coupland GA; Fox RM; Coates AS; Woods RL; Ng AB
J Surg Oncol; 1983 Aug; 23(4):223-7. PubMed ID: 6192289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
